Anti-SNCAIP antibodies are used in the immunodetection of the protein synuclein alpha interacting protein. In humans, the canonical protein has a reported length of 919 amino acid residues and a mass of 100.4 kDa. Its subcellular localization is in the cytoplasm. Up to 6 different isoforms have been reported for this protein. It is notably expressed in the brain. SNCAIP is known to be involved with metabolic processes. Post-translational modifications have been described, including ubiquitination. The SNCAIP gene has been associated with the disease, Parkinson disease. Synonyms for this target antigen include Sph1, synphilin-1, and SYPH1. SNCAIP gene orthologs have been reported in the mouse, rat, bovine, frog, zebrafish, chimpanzee and chicken species. Some SNCAIP antibodies may have been used in research and have associated citations. Immunohistochemistry is a widely used application for these antibodies. ELISA, Western Blot, and Immunofluorescence are also common applications.